Publications-ELK Biotechnology CO.,Ltd.

Technical

IF：4.7 Date：2026-03-11

International Immunopharmacology

Cepharanthine protects against lipopolysaccharide-induced acute lung injury in mice by blocking NLRP3 inflammasome activation

Products： EP013
IF：4.7 Date：2026-06-10

European Journal of Pharmacology

Design, synthesis, and inhibition of oxidative, amyloidogenic, and cholinergic dysfunction of saxagliptin-derived schiff bases against STZ-induced sporadic AD-like pathology

Products： ELK5988
IF：4.638 Date：2022-06-22

BMC CANCER

Ferroptosis-related long non-coding RNA signature predicts the prognosis of bladder cancer

Products： EQ001、 EQ003
IF：4.631 Date：2022-11-29

Journal of Inflammation Research

Oral Lycopene Administration Attenuates Inflammation and Oxidative Stress by Regulating Plasma Lipids in Rats with Lipopolysaccharide-Induced Epididymitis

Products： ELK1148、 ELK1158、 ELK1272、 ELK1396、 ELK5504

< Page of 477 >